Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA; Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide/CSIC/Junta de Andalucía, Seville 41013, Spain.
Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide/CSIC/Junta de Andalucía, Seville 41013, Spain.
Curr Biol. 2018 Jun 4;28(11):1681-1691.e4. doi: 10.1016/j.cub.2018.04.008. Epub 2018 May 17.
The organization and number of microtubules (MTs) in a cell depend on the proper regulation of MT nucleation. Currently, the mechanism of nucleation is the most poorly understood aspect of MT dynamics. XMAP215/chTOG/Alp14/Stu2 proteins are MT polymerases that stimulate MT polymerization at MT plus ends by binding and releasing tubulin dimers. Although these proteins also localize to MT organizing centers and have nucleating activity in vitro, it is not yet clear whether these proteins participate in MT nucleation in vivo. Here, we demonstrate that in the fission yeast Schizosaccharomyces pombe, the XMAP215 ortholog Alp14 is critical for efficient MT nucleation in vivo. In multiple assays, loss of Alp14 function led to reduced nucleation rate and numbers of interphase MT bundles. Conversely, activation of Alp14 led to increased nucleation frequency. Alp14 associated with Mto1 and γ-tubulin complex components, and artificially targeting Alp14 to the γ-tubulin ring complexes (γ-TuRCs) stimulated nucleation. In imaging individual nucleation events, we found that Alp14 transiently associated with a γ-tubulin particle shortly before the appearance of a new MT. The transforming acidic coiled-coil (TACC) ortholog Alp7 mediated the localization of Alp14 at nucleation sites but not plus ends, and was required for efficient nucleation but not for MT polymerization. Our findings provide the strongest evidence to date that Alp14 serves as a critical MT nucleation factor in vivo. We suggest a model in which Alp14 associates with the γ-tubulin complex in an Alp7-dependent manner to facilitate the assembly or stabilization of the nascent MT.
细胞中微管(MTs)的组织和数量取决于 MT 成核的正确调节。目前,成核机制是 MT 动力学中理解最不透彻的方面。XMAP215/chTOG/Alp14/Stu2 蛋白是 MT 聚合酶,通过结合和释放微管二聚体来刺激 MT 聚合在 MT 正极。尽管这些蛋白也定位于 MT 组织中心,并具有体外成核活性,但目前尚不清楚这些蛋白是否参与体内 MT 成核。在这里,我们证明裂殖酵母 Schizosaccharomyces pombe 中的 XMAP215 同源物 Alp14 对于体内高效 MT 成核至关重要。在多项测定中,Alp14 功能丧失会导致成核速率降低和间期 MT 束数量减少。相反,激活 Alp14 会导致成核频率增加。Alp14 与 Mto1 和γ-微管蛋白复合物成分相关,并且人为地将 Alp14 靶向γ-微管蛋白环复合物(γ-TuRCs)会刺激成核。在对单个成核事件进行成像时,我们发现 Alp14 在新 MT 出现之前,与γ-微管蛋白颗粒短暂相关。转化酸性卷曲螺旋(TACC)同源物 Alp7 介导 Alp14 在成核部位的定位,但不是正极,这对于有效成核是必需的,但对于 MT 聚合不是必需的。我们的发现提供了迄今为止最强的证据,证明 Alp14 是体内关键的 MT 成核因子。我们提出了一个模型,即 Alp14 以 Alp7 依赖的方式与γ-微管蛋白复合物相关联,以促进新 MT 的组装或稳定。